Studies documented hepatitis C treatment is safe and effective even when patients are monitored minimally during the course of DAA therapy. https://kirby.unsw.edu.au/news/new-research-hep-c-treatment-safe-and-effective-minimal-clinical-monitoring
This means countries with low coverage of hepatology speciality services could achieve their elimination targets through a proper task-shifting. Article A Path to Ending Hepatitis C in Ethiopia: A Phased Public He...
I fully agree with this event, the only problem is the risk of HCV re-infection with a different genotype
Fully realistic, now that DAAs are available at affordable cost. Only that one has block reinfection routes e.g. IV drug abuse, proper screening of blood before transfusion especially where it is needed repeatedly
- Badges
- Science topic
- Similar topics
- Medicine
- Disease
- Infectious Diseases